China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | -18.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | -18.01% | |||
| Cost of Revenue | -0.48% | -15.11% | |||
| Gross Profit | -0.48% | -18.96% | |||
| SG&A Expenses | -0.48% | -2.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.48% | -6.15% | |||
| Operating Income | -0.48% | -50.30% | |||
| Income Before Tax | -0.48% | -66.72% | |||
| Income Tax Expenses | -0.48% | -69.92% | |||
| Earnings from Continuing Operations | -0.48% | -65.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.48% | -65.51% | |||
| EBIT | -0.48% | -50.30% | |||
| EBITDA | -5.96% | -49.40% | |||
| EPS Basic | 0.00% | -65.62% | |||
| Normalized Basic EPS | 0.00% | -67.34% | |||
| EPS Diluted | -0.51% | -65.62% | |||
| Normalized Diluted EPS | 0.00% | -67.34% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | 0.00% | -0.25% | |||